1-11 of 11
Catherine Billups
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1617: Analysis of single mouse tumor response results from the Pediatric Preclinical Testing Program (PPTP)

Free
Brendan Murphy, Han Yin, John M. Maris, Anders E. Kolb, Richard Gorlick, Patrick C. Reynolds, Min Kang, Stephen T. Keir, Raushan Kurmasheva, Igor Dvorchik, Jianrong Wu, Catherine Billups, Malcolm A. Smith, Peter J. Houghton
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1617.
https://doi.org/10.1158/1538-7445.AM2015-1617
Published: 01 August 2015
View article titled, Abstract 1617: Analysis of single mouse tumor response results from the Pediatric Preclinical Testing Program (PPTP)
Journal Articles

Abstract 3969: Pediatric preclinical testing program (PPTP) evaluation of BMN 673, an inhibitor of poly-adp ribose polymerase (PARP), with temozolomide (TMZ)

Free
Malcolm Smith, Min Kang, Patrick Reynolds, Richard Gorlick, Anders Kolb, John Maris, Richard Lock, Hernan Carol, Stephen Keir, Catherine Billups, Raushan Kurmasheva, Peter Houghton
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 3969.
https://doi.org/10.1158/1538-7445.AM2014-3969
Published: 01 October 2014
View article titled, Abstract 3969: Pediatric preclinical testing program (PPTP) evaluation of BMN 673, an inhibitor of poly-adp ribose polymerase (PARP), with temozolomide (TMZ)
Journal Articles

Abstract 2755: Pediatric Preclinical Testing Program (PPTP) stage 1 evaluation of NSC750854, a sulfamated purine analog with a distinctive anticancer activity profile.

Free
Malcolm Smith, Min Kang, Patrick Reynolds, Richard Gorlick, Anders Kolb, John Maris, Stephen Keir, Catherine Billups, Raushan Kurmasheva, Peter Houghton, Jerry Collins
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2755.
https://doi.org/10.1158/1538-7445.AM2013-2755
Published: 15 April 2013
View article titled, Abstract 2755: Pediatric Preclinical Testing Program (PPTP) stage 1 evaluation of NSC750854, a sulfamated purine analog with a distinctive anticancer activity profile.
Journal Articles

Abstract 2758: Pediatric preclinical testing program (PPTP) stage 1 evaluation of MLN0128, a potent TOR kinase inhibitor.

Free
Peter Houghton, Min H. Kang, Patrick Reynolds, Richard Lock, Hernan Carol, Richard Gorlick, Anders Kolb, John Maris, Stephen Keir, Catherine Billups, Raushan Kurmasheva, Malcolm Smith
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2758.
https://doi.org/10.1158/1538-7445.AM2013-2758
Published: 15 April 2013
View article titled, Abstract 2758: Pediatric preclinical testing program (PPTP) stage 1 evaluation of MLN0128, a potent TOR kinase inhibitor.
Journal Articles

Abstract LB-354: Pediatric Preclinical Testing Program (PPTP) stage 1 evaluation of the XPO1/CRM1 inhibitor KPT-330.

Free
Peter Houghton, Min Kang, Patrick Reynolds, Richard Gorlick, Anders Kolb, John Maris, Stephen Keir, Hernan Carol, Richard Lock, Catherine Billups, Raushan Kurmasheva, Yosef Landesman, Sharon Shacham, Michael Kauffman, Malcolm A. Smith
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): LB-354.
https://doi.org/10.1158/1538-7445.AM2013-LB-354
Published: 15 April 2013
View article titled, Abstract LB-354: Pediatric Preclinical Testing Program (PPTP) stage 1 evaluation of the XPO1/CRM1 inhibitor KPT-330.
Journal Articles

Abstract LB-353: Pediatric Preclinical Testing Program (PPTP) stage 1 evaluation of cabozantinib.

Free
Malcolm Smith, Min Kang, Patrick Reynolds, Richard Gorlick, Anders Kolb, John Maris, Stephen Keir, Catherine Billups, Raushan Kurmasheva, Peter Houghton
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): LB-353.
https://doi.org/10.1158/1538-7445.AM2013-LB-353
Published: 15 April 2013
View article titled, Abstract LB-353: Pediatric Preclinical Testing Program (PPTP) stage 1 evaluation of cabozantinib.
Journal Articles

Abstract LB-317: Pediatric Preclinical Testing Program (PPTP) evaluation of volasertib (BI 6727), a Polo-like kinase (PLK) inhibitor

Free
Malcolm Smith, Stephen Keir, John Maris, Anders Kolb, Patrick Reynolds, Min Kang, Hernan Carol, Richard Lock, Richard Gorlick, Raushan Kurmasheva, Catherine Billups, Peter Houghton
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): LB-317.
https://doi.org/10.1158/1538-7445.AM2012-LB-317
Published: 15 April 2012
View article titled, Abstract LB-317: Pediatric Preclinical Testing Program (PPTP) evaluation of volasertib (BI 6727), a Polo-like kinase (PLK) inhibitor
Journal Articles

The Insulin-like Growth Factor-1 Receptor–Targeting Antibody, CP-751,871, Suppresses Tumor-Derived VEGF and Synergizes with Rapamycin in Models of Childhood Sarcoma

Free
Raushan T. Kurmasheva, Lorina Dudkin, Catherine Billups, Larisa V. Debelenko, Christopher L. Morton, Peter J. Houghton
Journal: Cancer Research
Cancer Res (2009) 69 (19): 7662–7671.
https://doi.org/10.1158/0008-5472.CAN-09-1693
Published: 01 October 2009
View article titled, The Insulin-like Growth Factor-1 Receptor–Targeting Antibody, CP-751,871, Suppresses Tumor-Derived VEGF and Synergizes with Rapamycin in Models of Childhood Sarcoma
Open the PDF for The Insulin-like Growth Factor-1 Receptor–Targeting Antibody, CP-751,871, Suppresses Tumor-Derived VEGF and Synergizes with Rapamycin in Models of Childhood Sarcoma in another window
Includes: Supplementary data
Journal Articles

Abstract #2806: Simultaneous targeting of mTORC1 and the IGF-I receptor for treatment of childhood sarcomas

Free
Raushan Kurmasheva, Lorina Dudkin, Catherine Billups, Larisa Debelenko, Christopher Morton, Peter Houghton
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 2806.
Published: 01 May 2009
View article titled, Abstract #2806: Simultaneous targeting of mTORC1 and the IGF-I receptor for treatment of childhood sarcomas
Journal Articles

p18Ink4c and p53 Act as Tumor Suppressors in Cyclin D1–Driven Primitive Neuroectodermal Tumor

Free
Raya Saab, Carlos Rodriguez-Galindo, Kelly Matmati, Jerold E. Rehg, Shannon H. Baumer, Joseph D. Khoury, Catherine Billups, Geoffrey Neale, Kathleen J. Helton, Stephen X. Skapek
Journal: Cancer Research
Cancer Res (2009) 69 (2): 440–448.
https://doi.org/10.1158/0008-5472.CAN-08-1892
Published: 15 January 2009
View article titled, p18Ink4c and p53 Act as Tumor Suppressors in Cyclin D1–Driven Primitive Neuroectodermal Tumor
Open the PDF for p18Ink4c and p53 Act as Tumor Suppressors in Cyclin D1–Driven Primitive Neuroectodermal Tumor in another window
Includes: Supplementary data
Journal Articles

Association of membrane-bound intercellular adhesion molecule-2 (ICAM-2) with alpha-actinin and the actin cytoskeleton as a determinant of the metastatic potential of neuroblastoma cells

Free
K. Jin Yoon, Joanna Remack, Rebecca Bush, Catherine Billups, Joseph Khoury, Mary Danks
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 531.
Published: 01 May 2007
View article titled, Association of membrane-bound intercellular adhesion molecule-2 (ICAM-2) with alpha-actinin and the actin cytoskeleton as a determinant of the metastatic potential of neuroblastoma cells